Literature DB >> 20065899

Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing.

Godela Brosnahan1, Mony Fraer.   

Abstract

Chronic kidney disease has become a major public health problem due to its high prevalence, its exorbitant cost, and large reductions in life expectancy and quality of life of affected people. Seventy percent of cases of end-stage renal disease are due to diabetes and hypertension, conditions which are usually managed by primary care providers. Other risk factors are cardiovascular disease, obesity, smoking, family history of kidney disease, and age greater than 55 years. Patients with these risk factors should be evaluated for the presence of chronic kidney disease during their primary care visits, because effective treatments for slowing progression are available, particularly if instituted early. Chronic kidney disease can be diagnosed by simple blood and urine tests, as recommended in guidelines issued by the National Kidney Foundation. This article begins with a case vignette, representing a common clinical scenario from a general internist's practice. We then review the definition and classification of chronic kidney disease, the epidemiology, etiology, and interconnections with cardiovascular disease. We discuss the guidelines for screening and laboratory testing, as well as the limitations of current assessment tools. A subsequent article will review evidence-based management of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065899     DOI: 10.1097/SMJ.0b013e3181c99438

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  8 in total

1.  Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease.

Authors:  Lesley Gardiner; Adebayo Akintola; Gang Chen; Jeffrey M Catania; Vishal Vaidya; Robert C Burghardt; Joseph V Bonventre; Jerome Trzeciakowski; Alan R Parrish
Journal:  Am J Nephrol       Date:  2012-01-20       Impact factor: 3.754

2.  Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran.

Authors:  Iraj Najafi; Fatemeh Attari; Farhad Islami; Ramin Shakeri; Fatemeh Malekzadeh; Rasool Salahi; Mina Yapan Gharavi; Mostafa Hosseini; Behrooz Broumand; Ali Nobakht Haghighi; Bagher Larijani; Reza Malekzadeh
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

Review 3.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

4.  Hepatoprotective effect of feeding celery leaves mixed with chicory leaves and barley grains to hypercholesterolemic rats.

Authors:  Nehal M Abd El-Mageed
Journal:  Pharmacogn Mag       Date:  2011-04       Impact factor: 1.085

5.  Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study.

Authors:  Leandro de Moraes Kohl; Luis Ulisses Signori; Rodrigo Antonini Ribeiro; Antonio Marcos Vargas Silva; Paulo Ricardo Moreira; Thiago Dipp; Graciele Sbruzzi; Janice Luisa Lukrafka; Rodrigo Della Méa Plentz
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  The Study of Pattern of Lipid Profile in Chronic Kidney Disease Patients on Conservative Management and Hemodialysis: A Comparative Study.

Authors:  Manpreet Saini; Amrita Vamne; Vijay Kumar; M S Chandel
Journal:  Cureus       Date:  2022-01-23

7.  Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells.

Authors:  Rattiyaporn Kanlaya; Supaporn Khamchun; Chompunoot Kapincharanon; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

8.  Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice.

Authors:  Theun de Groot; Lars Damen; Leanne Kosse; Mohammad Alsady; Rosalinda Doty; Ruben Baumgarten; Susan Sheehan; Johan van der Vlag; Ron Korstanje; Peter M T Deen
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.